what does glenmark pharmaceuticals do

Glenmark Pharmaceuticals Limited is a global research-led pharmaceutical company that develops, manufactures, and markets a wide range of generic, specialty, and over-the-counter (OTC) medicines and healthcare products across more than 80 countries worldwide.

what does glenmark clotrimazole do

Glenmark Clotrimazole is an antifungal medication used to treat fungal skin infections such as athlete's foot, jock itch, ringworm, and other related conditions by inhibiting the growth of fungi.

what does glenmark pharmaceuticals make

Glenmark Pharmaceuticals makes a diverse portfolio of products including generic formulations of leading branded medicines, specialty drugs for various therapeutic areas, and OTC products for common health issues, leveraging its global manufacturing and R&D capabilities.

what does glenmark adderall look like

Glenmark Adderall is a prescription medication available as capsules in various strengths, typically containing a white or off-white colored spherical or capsule-shaped solid dosage form with no visible coatings or markings, intended for oral use.

how does glenmark clotrimazole work

Glenmark Clotrimazole works by disrupting the cell membrane of fungi, leading to leakage of cellular contents and ultimately inhibiting their growth and survival, thereby treating fungal skin infections effectively.

Glenmark Pharmaceuticals Limited (GLENMARK) Share Price Today — ₹2,414

Glenmark Pharmaceuticals Limited (GLENMARK) live stock price is ₹2,414 with a change of +0.43% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Glenmark Pharmaceuticals Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Glenmark Pharmaceuticals Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

GLENMARK

NSEBSE

F&O

Glenmark Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE935A01035· Scrip: 532296

EN हिन्दी ગુજરાતી मराठी

₹2,414.00

▲ 10.30 (+0.43%)

29/4/2026, 3:28:56 pm

NSE

₹2,414.00

▲ 10.30

+0.43%

BSE

₹2,410.60

▲ 5.65

+0.00%

245 trading days · 1Y period

TODAY 

Open2,418.70

High2,474.00

Low2,403.70

Prev Close2,403.70

Volume6.08L

Value₹147.8Cr

L: 2,403.70H: 2,474.00

52 WEEK

Low₹1,355.00

High₹2,474.00

95% of 52W range

Info

Face Value₹1

Listed2000-02-07

ISININE935A01035

SeriesA

BSE Scrip532296

Key Metrics

1D

+0.43%

1W

+7.77%

1M

+10.73%

3M

+21.32%

6M

+29.48%

Valuation

P/E (TTM)—

P/E (Qtr Ann.)48.95

P/Sales5.04

Mkt Cap₹61604 Cr

Growth (QoQ)

Revenue-1.35%

PAT-1.82%

EPS-1.75%

Profitability

EBITDA Margin17.1%

Net Margin10.3%

TTM EBITDA M.20.7%

TTM Net M.-0.5%

Dividend

Yield0.10%

Latest DPS₹2.5

Payout Ratio20.3%

Growth+0.00%

TTM Revenue

₹12214 Cr

TTM EBITDA

₹2525 Cr

TTM PAT

₹-58 Cr

TTM EPS

₹-2.22

Rev/Share

₹432.8

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	3388 Cr	2962 Cr	579 Cr	456 Cr	348 Cr	₹12.33
2024-09-30	3434 Cr	3001 Cr	593 Cr	473 Cr	354 Cr	₹12.55
2024-06-30	2330 Cr	1767 Cr	671 Cr	618 Cr	454 Cr	₹16.08
2024-03-31	3063 Cr	2859 Cr	682 Cr	531 Cr	-1214 Cr	₹-43.18
2023-12-31	2507 Cr	2997 Cr	-374 Cr	-521 Cr	-331 Cr	₹-12.45
2023-09-30	3207 Cr	3008 Cr	17 Cr	-124 Cr	-64 Cr	₹-2.90
2023-03-31	3374 Cr	3025 Cr	-344 Cr	-491 Cr	-403 Cr	₹-15.18
2022-12-31	3464 Cr	3103 Cr	633 Cr	471 Cr	291 Cr	₹9.66

Shareholding Pattern

CURRENT — 2026-03-31

Promoter46.6%

FII20.3%

DII19.3%

Public53.4%

Govt0.0%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-10-03	Dividend	Interim Dividend - Rs 2.50 Per Share
2025-09-15	Dividend	Dividend - Rs 2.50 Per Share
2024-09-13	Dividend	Dividend - Rs 2.50 Per Share
2023-09-18	Dividend	Dividend - Rs 2.50 Per Share
2022-09-12	Dividend	Annual General Meeting/Dividend - Rs 2.50 Per Share
2021-09-08	Dividend	Annual General Meeting/Dividend - Rs 2.50 Per Share
2020-09-17	Dividend	Annual General Meeting/Dividend - Rs 2.50 Per Share
2019-09-19	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share
2018-09-19	Dividend	Annual General Meeting/Dividend Rs 2 Per Share
2017-09-20	Dividend	Annual General Meeting/Dividend - Rs 2/- Per Share
2016-08-03	Dividend	Annual General Meeting/ Dividend - Rs 2/- Per Share
2015-09-10	Dividend	Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-07-10	Dividend	Annual General Meeting / Dividend - Rs 2/- Per Share
2013-07-18	Dividend	Annual General Meeting / Dividend - Rs 2/- Per Share
2012-07-19	Dividend	Annual General Meeting / Dividend Rs 2 Per Share
2011-07-28	Dividend	Annual General Meeting And Dividend Re.0.40 Per Share
2010-09-16	Dividend	Annual General Meeting And Dividend Re.0.40 Per Share
2009-09-10	Other	Agm/Div-Re.0.40 Per Share
2008-09-18	Other	Annual General Meeting
2007-11-07	Dividend	Interim Dividend-70% Purpose Revised

Earnings Transcripts

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

14 Nov 2025NSE20K chars

Date	Open	High	Low	Close	Volume
2026-04-29	2,418.70	2,474.00	2,403.70	2,413.90	6.17L
2026-04-28	2,328.10	2,427.40	2,327.30	2,403.70	15.38L
2026-04-27	2,312.00	2,339.90	2,290.90	2,325.10	4.63L
2026-04-24	2,351.00	2,372.80	2,283.20	2,299.50	8.38L
2026-04-23	2,247.90	2,359.40	2,212.10	2,335.00	17.04L
2026-04-22	2,233.10	2,247.00	2,204.80	2,240.00	3.23L
2026-04-21	2,221.90	2,245.00	2,215.20	2,233.10	2.55L
2026-04-20	2,249.50	2,250.50	2,210.50	2,230.70	4.08L
2026-04-17	2,249.50	2,274.90	2,240.90	2,249.50	3.66L
2026-04-16	2,267.00	2,273.80	2,228.60	2,249.50	4.34L
2026-04-15	2,230.90	2,265.00	2,205.00	2,258.40	6.17L
2026-04-13	2,153.40	2,205.00	2,115.10	2,193.10	7.24L
2026-04-10	2,173.90	2,198.90	2,148.90	2,163.20	6.69L
2026-04-09	2,173.50	2,186.20	2,142.00	2,169.10	6.13L
2026-04-08	2,165.00	2,187.00	2,129.60	2,173.50	5.45L
2026-04-07	2,100.00	2,138.00	2,068.20	2,114.10	3.88L
2026-04-02	2,085.00	2,098.40	1,966.50	2,091.80	9.70L
2026-04-01	2,180.00	2,238.40	2,085.00	2,101.10	10.12L
2026-03-27	2,168.50	2,188.40	2,146.60	2,170.50	7.44L
2026-03-25	2,120.00	2,179.70	2,102.40	2,168.50	4.47L
2026-03-24	2,103.00	2,137.10	2,078.30	2,095.70	5.40L
2026-03-20	2,114.10	2,190.90	2,110.10	2,180.10	5.97L
2026-03-19	2,174.00	2,176.60	2,087.40	2,097.50	4.65L
2026-03-18	2,145.90	2,237.60	2,143.10	2,186.30	8.83L
2026-03-17	2,179.90	2,184.70	2,136.00	2,145.90	7.74L
2026-03-16	2,172.50	2,214.80	2,145.00	2,175.40	5.29L
2026-03-13	2,242.00	2,266.00	2,163.70	2,170.70	5.17L
2026-03-12	2,273.20	2,273.20	2,215.40	2,256.40	9.96L
2026-03-11	2,243.00	2,297.90	2,228.00	2,272.70	9.20L
2026-03-10	2,140.00	2,240.00	2,130.40	2,225.80	15.55L

GLENMARK

Key Metrics

Quarterly Financials

Shareholding Pattern

Corporate Actions

Earnings Transcripts

Price History

Frequently Asked Questions

Mutual Fund Holdings